Cargando…

Comment on: Ferrannini. Learning From Glycosuria. Diabetes 2011;60:695–696

Detalles Bibliográficos
Autor principal:	Stanton, Robert C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Online Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121419/ https://www.ncbi.nlm.nih.gov/pubmed/21709275 http://dx.doi.org/10.2337/db11-0483

Ejemplares similares

Response to Comment on: Ferrannini. Learning From Glycosuria. Diabetes 2011;60:695–696
por: Ferrannini, Ele
Publicado: (2011)

Comment on: Ott et al. Reduction in Basal Nitric Oxide Activity Causes Albuminuria. Diabetes 2011;60:572–576
por: Tsikas, Dimitrios, et al.
Publicado: (2011)

Response to Comment on: Ott et al. Reduction in Basal Nitric Oxide Activity Causes Albuminuria. Diabetes 2011;60:572–576
por: Ott, Christian, et al.
Publicado: (2011)

Comment on: Maruthur et al. Does Genetic Ancestry Explain Higher Values of Glycated Hemoglobin in African Americans? Diabetes 2011;60:2434–2438
por: Dagogo-Jack, Samuel
Publicado: (2012)

Response to Comment on: Maruthur et al. Does Genetic Ancestry Explain Higher Values of Glycated Hemoglobin in African Americans? Diabetes 2011;60:2434–2438
por: Maruthur, Nisa M., et al.
Publicado: (2012)

Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363
por: Sanda, Srinath, et al.
Publicado: (2011)

Comment on: Berhan. Thirty Years of Prospective Nationwide Incidence of Childhood Type 1 Diabetes: The Accelerating Increase by Time Tends to Level Off in Sweden. Diabetes 2011;60:577–581
por: Howard, Sarah G.
Publicado: (2011)

Response to Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363
por: Atkinson, Mark A.
Publicado: (2011)

Comment on: Kim et al. Deficiency for Costimulatory Receptor 4-1BB Protects Against Obesity-Induced Inflammation and Metabolic Disorders. Diabetes 2011;60:3159–3168
por: Gomez-Mejiba, Sandra E., et al.
Publicado: (2012)

Response to Comment on: Kim et al. Deficiency for Costimulatory Receptor 4-1BB Protects Against Obesity-Induced Inflammation and Metabolic Disorders. Diabetes 2011;60:3159–3168
por: Yu, Rina
Publicado: (2012)

Comment on: Høeg et al. Lipid-Induced Insulin Resistance Affects Women Less Than Men and Is Not Accompanied by Inflammation or Impaired Proximal Insulin Signaling. Diabetes 2011;60:64–73
por: Cusi, Kenneth
Publicado: (2011)

Response to Comment on: Høeg et al. Lipid-Induced Insulin Resistance Affects Women Less Than Men and Is Not Accompanied by Inflammation or Impaired Proximal Insulin Signaling. Diabetes 2011;60:64–73
por: Kiens, Bente, et al.
Publicado: (2011)

Influence of Gut Microbes on the Brain-Gut Axis (Gut 2011;60:307-317)
por: Lee, Yeong Yeh, et al.
Publicado: (2011)

Identification of metabolic modifiers that underlie phenotypic variations in energy-balance regulation. Diabetes 2011;60:726–734
por: Chang, CL, et al.
Publicado: (2013)

Erratum. Mediobasal Hypothalamic SIRT1 Is Essential for Resveratrol’s Effects on Insulin Action in Rats. Diabetes 2011;60:2691–2700
por: Knight, Colette M., et al.
Publicado: (2017)

Acute Tryptophan Depletion and Functional Brain Imaging in Irritable Bowel Syndrome (Gut 2011;60:1196-1203)
por: Kim, Hee Man
Publicado: (2012)

Erratum. Abrogation of MMP-9 Gene Protects Against the Development of Retinopathy in Diabetic Mice by Preventing Mitochondrial Damage. Diabetes 2011;60:3023–3033
por: Kowluru, Renu A., et al.
Publicado: (2021)

Increased expression and activity of 12-lipoxygenase in oxygen-induced ischemic retinopathy and proliferative diabetic retinopathy: implications in retinal neovascularization. Diabetes 2011;60:614–624
por: Al-Shabrawey, M, et al.
Publicado: (2013)

Learning From Glycosuria
por: Ferrannini, Ele
Publicado: (2011)

Non-Diabetic Glycosuria
Publicado: (1900)

Comment on: Selvin et al. sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death. Diabetes 2013;62:2116–2121
por: Schalkwijk, Casper G., et al.
Publicado: (2013)

Comment on: Selvin et al. sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death. Diabetes 2013;62:2116–2121
por: Yamagishi, Sho-ichi
Publicado: (2013)

Glycosuria
por: DeWolf, Oscar C.
Publicado: (1882)

Response to Comments on: Selvin et al. sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death. Diabetes 2013;62:2116–2121
por: Selvin, Elizabeth, et al.
Publicado: (2013)

Could Carbon Breath Test Measurement Accurately Reflect Gastric Emptying of Liquid Nutrient Meal in the Critically Ill Patients? (Gut 2011;60:1336-1343)
por: Kim, Ji Won
Publicado: (2012)

Comment on: Lazo et al. NH(2)-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes. Diabetes 2013;62:3189–3193
por: Moro, Cedric, et al.
Publicado: (2013)

Statement of Retraction. Hepatic Glucagon Action Is Essential for Exercise-Induced Reversal of Mouse Fatty Liver. Diabetes 2011;60:2720–2729. DOI: 10.2337/db11-0455
por: Berglund, Eric D., et al.
Publicado: (2016)

Comment on: Marquez et al. Low-Frequency Variants in HMGA1 Are Not Associated With Type 2 Diabetes Risk. Diabetes 2012;61:524–530
por: Brunetti, Antonio, et al.
Publicado: (2012)

Response to Comment on: Marquez et al. Low-Frequency Variants in HMGA1 Are Not Associated With Type 2 Diabetes Risk. Diabetes 2012;61:524–530
por: Froguel, Philippe, et al.
Publicado: (2012)

Comment on: Allister et al. UCP2 Regulates the Glucagon Response to Fasting and Starvation. Diabetes 2013;62:1623–1633
por: Gylfe, Erik
Publicado: (2013)

Comment on: Greenbaum et al. Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes. Diabetes 2012;61:1323–1330
por: Vialettes, Bernard, et al.
Publicado: (2012)

Comment on: Straznicky et al. Neuroadrenergic Dysfunction Along the Diabetes Continuum: A Comparative Study in Obese Metabolic Syndrome Subjects. Diabetes 2012;61:2506–2516
por: Frontoni, Simona
Publicado: (2013)

Erratum. APPL1 Counteracts Obesity-Induced Vascular Insulin Resistance and Endothelial Dysfunction by Modulating the Endothelial Production of Nitric Oxide and Endothelin-1 in Mice. Diabetes 2011;60:3044–3054
por: Wang, Yi, et al.
Publicado: (2016)

Comment on: Korpos et al. The Peri-islet Basement Membrane, a Barrier to Infiltrating Leukocytes in Type 1 Diabetes in Mouse and Human. Diabetes 2013;62:531–542
por: Simeonovic, Charmaine J., et al.
Publicado: (2013)

Response to Comment on: Greenbaum et al. Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes. Diabetes 2012;61:1323–1330
por: Greenbaum, Carla J., et al.
Publicado: (2012)

Response to Comment on: Straznicky et al. Neuroadrenergic Dysfunction Along the Diabetes Continuum: A Comparative Study in Obese Metabolic Syndrome Subjects. Diabetes 2012;61:2506–2516
por: Straznicky, Nora E., et al.
Publicado: (2013)

Comment on: Meagher et al. Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes 2010;59:2862–2871
por: Vendrame, Francesco, et al.
Publicado: (2011)

Response to Comment on: Allister et al. UCP2 Regulates the Glucagon Response to Fasting and Starvation. Diabetes 2013;62:1623–1633
por: Hardy, Alexandre B., et al.
Publicado: (2013)

Response to Comment on: Meagher et al. Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes 2010;59:2862–2871
por: Meagher, Craig, et al.
Publicado: (2011)

Comment on: Sørensen et al. Maternal Serum Levels of 25-Hydroxy-Vitamin D During Pregnancy and Risk of Type 1 Diabetes in the Offspring. Diabetes 2012;61:175–178
por: Niinistö, Sari, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3m8hkla1486qrjasclq1cahr85